Clinical trial of triple combination therapy reveals clues to lung cancer treatment resistance
In a new clinical trial, researchers have interrogated how patients with an aggressive form of lung cancer respond to treatment with a triple combination therapy.
Read original article on The Medical News →Related news
-
New guidance outlines use of first immunotherapy for children newly diagnosed with type 1 diabetes
United Kingdom
-
Rare genetic discovery explains sex development differences in two XY sisters
United Kingdom
-
First complete genomes for neglected malaria parasites revealed
United Kingdom
-
AI used to better predict kidney stone composition
United Kingdom
-
Cell changes around early breast cancers provide clues to why some cases become invasive
United Kingdom
-
'Punch in the gut': Homes sales fall to their lowest in 16 years
United States
-
American Cancer Society updates prostate cancer screening guideline: Regular PSA testing for average- and high-risk men
United Kingdom
-
Inflammation is involved in the earliest stages of atherosclerosis
United Kingdom